These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38750780)

  • 41. Galectin-3 in septic acute kidney injury: a translational study.
    Sun H; Jiang H; Eliaz A; Kellum JA; Peng Z; Eliaz I
    Crit Care; 2021 Mar; 25(1):109. PubMed ID: 33736691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum uromodulin and progression of kidney disease in patients with chronic kidney disease.
    Lv L; Wang J; Gao B; Wu L; Wang F; Cui Z; He K; Zhang L; Chen M; Zhao MH
    J Transl Med; 2018 Nov; 16(1):316. PubMed ID: 30454063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical factors for predicting cardiovascular risk, need for renal replacement therapy, and mortality in patients with non-dialysis-dependent stage 3-5 chronic kidney disease from the Salford Kidney Study.
    Filipa Alexandre A; Stoelzel M; Kiran A; Garcia-Hernandez A; Morga A; Kalra PA
    J Nephrol; 2023 Jul; 36(6):1639-1649. PubMed ID: 37289366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of Galectins in the Liver Diseases: A Systematic Review and Meta-Analysis.
    An Y; Xu S; Liu Y; Xu X; Philips CA; Chen J; Méndez-Sánchez N; Guo X; Qi X
    Front Med (Lausanne); 2021; 8():744518. PubMed ID: 34778306
    [No Abstract]   [Full Text] [Related]  

  • 45. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
    Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
    Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Galectin-3 levels in children with cystic fibrosis.
    Ademhan Tural D; Emiralioglu N; Akin S; Alboga D; Ozsezen B; Nayir Buyuksahin H; Guzelkas I; Kasikci M; Sunman B; Gungor I; Yalcin E; Dogru D; Kiper N; Demirel AH; Ozcelik U
    Eur J Pediatr; 2024 May; 183(5):2333-2342. PubMed ID: 38430280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Shuai T; Yan P; Xiong H; Huang Q; Zhu L; Yang K; Liu J
    Biomed Res Int; 2019; 2019():6927456. PubMed ID: 31886242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dietary interventions for adults with chronic kidney disease.
    Palmer SC; Maggo JK; Campbell KL; Craig JC; Johnson DW; Sutanto B; Ruospo M; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011998. PubMed ID: 28434208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation.
    Opotowsky AR; Baraona F; Owumi J; Loukas B; Singh MN; Valente AM; Wu F; Cheng S; Veldtman G; Rimm EB; Landzberg MJ
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26755550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of serum galectin-3 in hospitalized patients with COVID-19.
    Özcan S; Dönmez E; Yavuz ST; Ziyrek M; İnce O; Küçük HS; Taşdemir ZA; Yılmaz İ; Varol S; Şahin İ; Okuyan E
    Cytokine; 2022 Oct; 158():155970. PubMed ID: 35917725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of galectin-3 in adults with congenital heart disease.
    Baggen VJM; van den Bosch AE; Eindhoven JA; Menting ME; Witsenburg M; Cuypers JAAE; Boersma E; Roos-Hesselink JW
    Heart; 2018 Mar; 104(5):394-400. PubMed ID: 28942393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Galectins-1, -3, -7, -8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
    Pergialiotis V; Papoutsi E; Androutsou A; Tzortzis AS; Frountzas M; Papapanagiotou A; Kontzoglou K
    Int J Gynaecol Obstet; 2021 Mar; 152(3):299-307. PubMed ID: 33156523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal function largely influences Galectin-3 prognostic value in heart failure.
    Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of neutrophil-to-lymphocyte ratio and risk of cardiovascular or all-cause mortality in chronic kidney disease: a meta-analysis.
    Ao G; Wang Y; Qi X; Wang F; Wen H
    Clin Exp Nephrol; 2021 Feb; 25(2):157-165. PubMed ID: 33025234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galectin-3 is an independent predictor of survival in systemic sclerosis.
    Faludi R; Nagy G; Tőkés-Füzesi M; Kovács K; Czirják L; Komócsi A
    Int J Cardiol; 2017 Apr; 233():118-124. PubMed ID: 28043664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between Serum Inorganic Phosphorus Levels and Adverse Outcomes in Chronic Kidney Disease: The Fukushima CKD Cohort Study.
    Oda A; Tanaka K; Saito H; Iwasaki T; Watanabe S; Kimura H; Kazama S; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Intern Med; 2022 Jun; 61(11):1653-1662. PubMed ID: 34803092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of hypochloremia versus hyponatremia among patients with chronic kidney disease-a retrospective cohort study.
    Kubota K; Sakaguchi Y; Hamano T; Oka T; Yamaguchi S; Shimada K; Matsumoto A; Hashimoto N; Mori D; Matsui I; Isaka Y
    Nephrol Dial Transplant; 2020 Jun; 35(6):987-994. PubMed ID: 30346587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes: A Systematic Review and Meta-Analysis.
    Chen Q; Wang Z; Zhou J; Chen Z; Li Y; Li S; Zhao H; Badve SV; Lv J
    Clin J Am Soc Nephrol; 2020 Nov; 15(11):1576-1586. PubMed ID: 33055192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antioxidants for adults with chronic kidney disease.
    Colombijn JM; Hooft L; Jun M; Webster AC; Bots ML; Verhaar MC; Vernooij RW
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD008176. PubMed ID: 37916745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.